Free tool
Stocks far below their 52-week high
We cover 155 companies trading at least 50% below their own 52-week high. The median market value in the group is $12.76M. Across the group, the median move over the past trading day is 0.00%. 11% of the 152 with a 200-day average trade above it. Price change over the past year runs from −86.9% to −1.2% across the middle 80 percent of the group, with a median of −54.0%.
Other lists in this group
Table
155 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| ESL.DE | EssilorLuxottica Société anonyme | 160.00 EUR | −2.85% | −38.15% | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | 159.15 EUR | −3.60% | −38.64% | −38.15% |
| BSX.DE | Boston Scientific Corporation | 42.30 EUR | +3.18% | −47.52% | −53.11% |
| ZOE.DE | Zoetis Inc. | 65.74 EUR | −4.92% | −38.01% | −49.47% |
| AFW.DE | Align Technology, Inc. | 143.00 EUR | −6.14% | +7.68% | −54.37% |
| EVT.DE | Evotec SE | 3.25 EUR | −6.22% | −41.07% | −45.75% |
| 2HQ0.DE | Tilray Brands, Inc. | 4.07 EUR | +21.13% | −48.80% | −67.56% |
| CRW.L | Craneware plc | 1,272.00 GBP | +2.75% | −33.40% | −40.83% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | 1.04 EUR | +0.97% | −90.91% | −90.91% |
| AGY.L | Allergy Therapeutics plc | 5.60 GBP | −5.08% | −52.94% | −30.00% |
| N3B.F | Anbio Biotechnology | 6.40 EUR | −24.26% | −62.13% | −83.42% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | 13.50 EUR | +8.87% | −48.77% | +47.70% |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% |
| SANION.ST | Saniona AB (publ) | 11.83 SEK | −15.32% | −43.93% | −12.37% |
| ALSEN.PA | Sensorion SA | 0.28 EUR | −0.71% | −17.01% | −14.20% |
| CRNO-B.ST | Cereno Scientific AB (publ) | 4.71 SEK | +0.13% | −32.04% | −53.59% |
| SCLP.L | Scancell Holdings plc | 9.70 GBP | −2.02% | −2.02% | −7.62% |
| GBT.PA | Guerbet SA | 7.92 EUR | +3.80% | −46.41% | −61.92% |
| FARON.HE | Faron Pharmaceuticals Oy | 0.48 EUR | −0.92% | −78.79% | −79.42% |
| FARN.L | Faron Pharmaceuticals Oy | 41.00 GBP | −4.65% | −78.97% | −79.24% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.70 SEK | −12.97% | −47.45% | −60.78% |
| EAPI.PA | Euroapi S.A. | 0.95 EUR | −24.88% | −56.91% | −68.63% |
| ABNX.PA | ABIONYX Pharma SA | 1.97 EUR | +5.79% | −49.58% | −31.34% |
| ADOC.PA | Adocia SA | 4.01 EUR | −0.20% | −40.42% | −54.33% |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% |
| EQL.ST | EQL Pharma AB (publ) | 27.05 SEK | +34.58% | −54.31% | −67.01% |
| AB.PA | AB Science S.A. | 0.74 EUR | +32.68% | −49.38% | −38.62% |
| DICOT.ST | Dicot Pharma AB | 0.21 SEK | +13.89% | −32.06% | −76.06% |
| STX.L | Shield Therapeutics plc | 4.85 GBP | −15.65% | −50.76% | −37.42% |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.93% | −66.11% | −67.92% |
| MAAT.PA | MaaT Pharma SA | 3.04 EUR | +8.96% | −45.52% | −33.91% |
| HEALTH.HE | Nightingale Health Oyj | 0.93 EUR | +9.95% | −55.38% | −57.24% |
| V3V.DE | FamiCord AG | 2.86 EUR | +0.70% | −52.73% | −61.35% |
| ALKLH.PA | Klea Holding SA | 0.15 EUR | −4.73% | −31.24% | −32.00% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 588.00 GBP | −8.12% | +3.52% | +70.43% |
| EPIS-B.ST | Episurf Medical AB (publ) | 0.08 SEK | +37.70% | +90.12% | +71.52% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% |
| XSPRAY.ST | Xspray Pharma AB (publ) | 10.74 SEK | −35.77% | −64.61% | −76.00% |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% |
| HRTIS.HE | Herantis Pharma Oyj | 1.69 EUR | +6.42% | −26.20% | −2.31% |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −9.52% | −20.83% | −26.92% |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.40 EUR | −2.44% | −37.50% | −46.67% |
| OSSD.ST | OssDsign AB (publ) | 4.00 SEK | −10.01% | −64.60% | −73.26% |
| MPAL.L | MedPal AI PLC | 3.75 GBP | +22.95% | −25.00% | −40.00% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +16.21% | +21.19% | +7.38% |
| OPTOMED.HE | Optomed Oyj | 1.71 EUR | +6.36% | −54.99% | −54.39% |
| ORT-B.ST | Ortoma AB (publ) | 7.80 SEK | −13.24% | −42.22% | −66.52% |
| QLINEA.ST | Q-linea AB (publ) | 18.70 SEK | +8.41% | −35.52% | −62.97% |
| BXT.DE | BioNxt Solutions Inc. | 0.22 EUR | +5.26% | −48.72% | −65.52% |
| BRETEC.HE | Bioretec Oy | 0.02 EUR | +5.77% | −96.58% | −98.25% |
| IMM.L | ImmuPharma plc | 3.41 GBP | −24.22% | −45.00% | +89.66% |
| ALIMP.PA | Implanet S.A. | 0.19 EUR | +13.05% | −8.35% | −2.68% |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% |
| RENX.L | Renalytix Plc | 4.30 GBP | +62.26% | −27.12% | −26.50% |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% |
| MAK.DE | Maternus-Kliniken Aktiengesellschaft | 0.92 EUR | −3.16% | −6.60% | −22.03% |
| SCIB.ST | SciBase Holding AB (publ) | 20.40 SEK | −34.19% | −18.40% | −29.25% |
| XBRANE.ST | Xbrane Biopharma AB (publ) | 9.36 SEK | −6.40% | −9.77% | −72.31% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −79.17% |
| ELIC.ST | Elicera Therapeutics AB (publ) | 2.70 SEK | +13.71% | −47.97% | −61.50% |
| ALZ.ST | Alzinova AB (publ) | 0.84 SEK | −13.70% | +0.48% | −39.02% |
| DMYD-B.ST | Diamyd Medical AB (publ) | 1.03 SEK | −0.39% | −91.17% | −90.97% |
| PRO.ST | Promimic AB (publ) | 8.50 SEK | −18.27% | −44.98% | −41.38% |
| XINT.ST | Xintela AB (publ) | 0.18 SEK | −8.31% | −37.88% | −51.08% |
| AELIS.PA | Aelis Farma SA | 1.03 EUR | +0.39% | −11.21% | −19.22% |
| GME.DE | Geratherm Medical AG | 2.58 EUR | +1.18% | −10.42% | −16.50% |
| APTA.L | Aptamer Group PLC | 0.38 GBP | −21.05% | −63.94% | −62.50% |
| POXEL.PA | Poxel S.A. | 0.21 EUR | +7.11% | −7.16% | −34.76% |
| ACTI.ST | Active Biotech AB (publ) | 5.50 SEK | +6.38% | +19.57% | −62.00% |
| NICA.ST | Nanologica AB (publ) | 0.44 SEK | −3.30% | −41.33% | −69.86% |
| PTRK.ST | Physitrack PLC | 8.06 SEK | −0.49% | −38.71% | −57.58% |
| IZAFE-B.ST | iZafe Group AB (publ) | 0.31 SEK | 0.00% | −33.26% | −17.57% |
| ALNFL.PA | NFL Biosciences SA | 0.90 EUR | +7.96% | −25.42% | −39.12% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.19 SEK | −12.36% | −39.58% | −47.36% |
| ICO.ST | Iconovo AB (publ) | 1.26 SEK | +26.00% | +12.50% | −52.09% |
| LIFE.OL | Lifecare ASA | 0.30 NOK | −11.94% | −51.51% | −97.23% |
| ALBPS.PA | Biophytis S.A. | 0.08 EUR | +422.88% | +28.41% | −50.31% |
| SVNS.L | Solvonis Therapeutics plc | 0.12 GBP | −11.59% | −61.88% | −55.64% |
| F98.F | CytoMed Therapeutics Limited | 0.84 EUR | +12.08% | −73.06% | −50.30% |
| ALSGD.PA | SpineGuard SA | 0.10 EUR | +13.91% | +1.93% | +8.08% |
| VIVE.ST | Vivesto AB | 8.90 SEK | +3.01% | −21.10% | −57.13% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | 13.60 SEK | +7.09% | −31.66% | −46.03% |
| CMOTEC-B.ST | Scandinavian ChemoTech AB | 3.05 SEK | −4.69% | −33.84% | −19.74% |
| IMMNOV.ST | Immunovia AB (publ) | 0.15 SEK | −15.58% | −33.66% | −70.74% |
| BIBB.ST | BiBBInstruments AB | 0.59 SEK | −14.70% | −83.74% | −84.94% |
| SPAGO.ST | Spago Nanomedical AB (publ) | 0.12 SEK | +1.32% | +4.55% | −54.00% |
| EXTX.OL | EXACT Therapeutics AS | 0.75 NOK | +13.64% | −47.55% | −65.60% |
| CLS-B.ST | Clinical Laserthermia Systems AB (publ) | 1.86 SEK | −3.83% | −72.67% | −75.86% |
| GENI.L | GENinCode Plc | 0.90 GBP | +12.50% | −62.50% | −35.71% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.61 SEK | +16.48% | −81.26% | −88.08% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | 1.50 GBP | −26.83% | −3.23% | +7.14% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | 2.57 SEK | −6.55% | +110.66% | −0.39% |
| OPTI.L | OptiBiotix Health Plc | 5.65 GBP | −1.74% | −16.30% | −51.91% |
| ABTEC.OL | Aqua Bio Technology ASA | 4.90 NOK | +0.41% | −79.58% | −87.89% |
| PRM.L | Proteome Sciences plc | 1.59 GBP | −11.94% | −44.39% | −44.39% |
| ERMA.ST | Enorama Pharma AB (publ) | 0.89 SEK | +193.73% | −55.16% | −67.04% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | 0.32 EUR | +2.57% | −18.41% | −19.44% |
| CHOSA.ST | Chosa Oncology AB | 0.73 SEK | −14.15% | −20.00% | −9.00% |
| VRCI.L | Verici Dx plc | 0.23 GBP | −35.71% | −68.97% | −57.14% |
| SYNT.ST | SyntheticMR AB (publ) | 0.72 SEK | +24.14% | −46.07% | −74.29% |
| OBD.L | Oxford BioDynamics Plc | 0.12 GBP | −1.60% | −50.80% | −74.11% |
| STENO.CO | Stenocare A/S | 0.95 DKK | −1.86% | −36.11% | −22.91% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | 0.37 SEK | +0.54% | +19.35% | −85.49% |
| PEXA-B.ST | PExA AB (publ) | 0.34 SEK | −31.80% | +48.26% | +79.47% |
| SBX.DE | SynBiotic SE | 0.74 EUR | −32.10% | −71.02% | −76.63% |
| NFX.L | Nuformix plc | 0.16 GBP | +6.71% | −46.10% | +80.68% |
| ALPAT.PA | Plant Advanced Technologies SA | 4.20 EUR | 0.00% | −48.91% | −53.33% |
| QLIFE.ST | Qlife Holding AB (publ) | 1.81 SEK | −6.91% | −30.80% | −52.47% |
| NEOLA.ST | Neola Medical AB (publ) | 0.49 SEK | −17.67% | −54.05% | −79.24% |
| BIOSGN.ST | Biosergen AB (publ) | 2.48 SEK | +262.31% | −93.80% | −94.62% |
| ODI.ST | ODI Pharma AB (publ) | 2.20 SEK | −5.17% | −48.36% | +39.24% |
| SERV.ST | Servana AB | 0.01 SEK | −16.22% | +210.00% | +106.67% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | −7.50% | −64.98% | −65.74% |
| ALBLU.PA | Bluelinea Société Anonyme | 0.17 EUR | −23.18% | −65.79% | −68.11% |
| FDBK.L | Feedback plc | 6.85 GBP | +13.22% | −36.28% | −48.30% |
| INDCT.OL | Induct AS | 0.77 NOK | −12.47% | −83.00% | −78.07% |
| PMED.ST | PEPTONIC medical AB (publ) | 0.00 SEK | +20.00% | −25.00% | −25.00% |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | 1.38 SEK | −0.36% | −91.79% | −93.99% |
| FUM.L | Futura Medical plc | 0.39 GBP | −2.26% | −68.29% | −95.67% |
| GUARD.ST | Disruptive Pharma AB (publ) | 1.47 SEK | −10.49% | +1.94% | −93.53% |
| BSFA.L | BSF Enterprise Plc | 1.15 GBP | +43.75% | −39.47% | −48.89% |
| PROGEN.ST | Prostatype Genomics AB (publ) | 0.16 SEK | −4.59% | −59.48% | −79.42% |
| VAL.L | ValiRx plc | 0.16 GBP | +3.33% | −57.53% | −73.04% |
| ZENI.ST | Zenicor Medical Systems AB (publ) | 0.97 SEK | +1.58% | −13.06% | −59.79% |
| SPEC.ST | SpectraCure AB (publ) | 0.03 SEK | −3.33% | −79.63% | −81.77% |
| IBAI.L | Imaging Biometrics Ltd. | 0.64 GBP | +5.83% | −25.29% | +2.42% |
| POLAR.ST | PolarCool AB (publ) | 1.73 SEK | +8.12% | −55.87% | −67.96% |
| GABA.ST | Gabather AB (publ) | 0.03 SEK | +10.00% | +6.94% | −17.20% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | 0.70 SEK | +16.33% | −27.14% | −58.08% |
| PHAL.ST | PharmaLundensis AB | 0.32 SEK | 0.00% | +8.19% | +37.83% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −32.46% | −91.74% | −99.27% |
| IMS.ST | Invent Medic Sweden AB (publ) | 0.10 SEK | +6.95% | −69.51% | −22.48% |
| APTA.ST | Aptahem AB (publ) | 0.56 SEK | −15.96% | −51.69% | −67.65% |
| MONI.ST | Monivent AB | 0.17 SEK | −5.71% | −49.39% | −37.02% |
| NANECH.ST | NanoEcho AB (publ) | 0.03 SEK | −3.51% | −57.96% | −72.03% |
| CHLL.L | Chill Brands Group PLC | 2.00 GBP | −9.09% | −74.19% | −87.88% |
| ALINT.PA | IntegraGen SA | 0.18 EUR | −18.86% | +32.22% | −36.25% |
| 2CUREX.ST | 2cureX AB (publ) | 0.66 SEK | −62.67% | +22.68% | −71.79% |
| ODIN.ST | Odinwell AB (publ) | 0.14 SEK | −25.80% | −50.71% | −61.25% |
| PTP.DE | Pentixapharm Holding AG | 1.85 EUR | −5.61% | +20.13% | +5.47% |
| LXB.ST | Luxbright AB (publ) | 0.06 SEK | −42.86% | −88.33% | −91.76% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | 0.40 SEK | −25.93% | −97.66% | −98.15% |
| ISAB.ST | Inhalation Sciences Sweden AB (publ) | 0.14 SEK | −35.19% | −70.34% | −73.58% |
| TRLS.L | Trellus Health plc | 0.04 GBP | +3233.33% | −90.00% | −94.29% |
| S2M.ST | S2Medical AB (publ) | 0.00 SEK | −11.11% | −52.00% | −63.08% |
| NIDHOG.ST | Nidhogg Resources Holding AB (publ) | 0.47 SEK | +16.75% | −41.99% | −72.69% |
| ALSAF.PA | Safe Orthopaedics SA | 0.64 EUR | 0.00% | −61.90% | −73.33% |
| SDET.ST | SensoDetect Aktiebolag (publ) | 0.00 SEK | −27.27% | −97.75% | −99.53% |
| ALNEV.PA | Neovacs S.A. | 0.55 EUR | −31.22% | +6150.00% | −11.29% |
| ADXN.SW | Addex Therapeutics Ltd | 0.03 CHF | −37.38% | −51.32% | −55.21% |
| COPN.SW | Cosmo NV | 57.80 CHF | −6.17% | −43.92% | −5.27% |
| MMTX.SW | MindMaze Therapeutics Holding SA | 0.16 CHF | −17.85% | −89.73% | −84.98% |
| NWRN.SW | Newron Pharmaceuticals S.p.A. | 12.48 CHF | +8.15% | −51.06% | +44.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.